Acetoxolone
Names | |
---|---|
IUPAC name 3β-(Acetyloxy)-11-oxoolean-12-en-30-oic acid | |
Systematic IUPAC name (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-(Acetyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid | |
Other names Acetylglycyrrhetinic acid | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEMBL |
|
ChemSpider |
|
ECHA InfoCard | 100.025.887 |
PubChem CID |
|
UNII |
|
InChI
| |
| |
Properties | |
Chemical formula | C32H48O5 |
Molar mass | 512.72 g/mol |
Pharmacology | |
A02BX09 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references |
Chemical compound
Acetoxolone (also known as acetylglycyrrhetic acid, acetylglycyrrhetinic acid, glycyrrhetinyl acetate and glycyrrhetic acid acetate) is a drug used for peptic ulcer and gastroesophageal reflux disease.[1] It is an acetyl derivative of glycyrrhetinic acid. It is found in Echinopora lamellosa.[1]
See also
References
- ^ a b PubChem. "Acetoxolone". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-11-25.
- v
- t
- e
analogues ("-prost-")
("-prazole")
acid blockers ("-prazan")
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
- See also: Helicobacter pylori eradication protocols
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e